Immunai, Inc.

Immunai is a biotech company using single-cell genomics, machine learning, and software engineering to map and reprogram the immune system. Its AMICA data foundation and AI models support discovery and development of therapeutics, including applications in cancer, autoimmune disease, and immuno-oncology. The company partners with biopharmaceutical companies and research institutions to identify targets, biomarkers, mechanisms of action, and other clinically relevant insights.